<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30642764</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-576X</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Revista espanola de cirugia ortopedica y traumatologia (English ed.)</Title><ISOAbbreviation>Rev Esp Cir Ortop Traumatol (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Ewing sarcoma, analysis of survival at 6 years with multidisciplinary therapy.</ArticleTitle><Pagination><StartPage>86</StartPage><EndPage>94</EndPage><MedlinePgn>86-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.recot.2018.10.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1888-4415(18)30170-X</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this study is to present our series of Ewing sarcoma cases and the survival data obtained in the medium term, using a multidisciplinary therapy protocol.</AbstractText><AbstractText Label="MATERIAL, METHODS AND RESULTS" NlmCategory="RESULTS">Forty-one Ewing sarcomas were diagnosed, treated and followed-up in our hospital between 2004 and 2009 with an average age of 18.29 years. Seventy-eight percent were to Ewing sarcoma of the bone, the femur being the most frequent location. Sixty-eight percent had a localized stage at the time of diagnosis. At the end of follow-up, 40% of the patients did not survive, most died within the first 5 years of follow-up.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">In Spain, Ewing sarcoma is the most common primary malignant bone tumour in childhood, ahead of osteosarcoma. Its survival rate has increased greatly in the last 40 years, improvement attributable mainly to the aggressive use of chemotherapy and to multidisciplinary treatment, but its prognosis remains very poor, especially for those with metastasis at diagnosis, the main adverse prognostic factor. Because of its high mortality, many authors consider it a disseminated disease from the beginning, with non- detectable micrometastasis that condition final survival.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Early diagnosis and multidisciplinary therapy in referral centres are the best strategies currently available to us to provide these patients the maximum possibilities of cure of this disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 SECOT. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borrego-Paredes</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital de &#xc9;cija, Sevilla, Espa&#xf1;a. Electronic address: estrellabp86@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prada-Chamorro</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chac&#xf3;n-Cartaya</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unidad de Tumores Musculoesquel&#xe9;ticos, Servicio de Cirug&#xed;a Ortop&#xe9;dica y Traumatolog&#xed;a, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Rodas</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Tumores Musculoesquel&#xe9;ticos, Servicio de Cirug&#xed;a Ortop&#xe9;dica y Traumatolog&#xed;a, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo-Ayala</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Unidad de Tumores Musculoesquel&#xe9;ticos, Servicio de Cirug&#xed;a Ortop&#xe9;dica y Traumatolog&#xed;a, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Beneit</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Unidad de Tumores Musculoesquel&#xe9;ticos, Servicio de Cirug&#xed;a Ortop&#xe9;dica y Traumatolog&#xed;a, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Sarcoma de Ewing, an&#xe1;lisis de supervivencia a los 6 a&#xf1;os con terapia multidisciplinar.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Cir Ortop Traumatol (Engl Ed)</MedlineTA><NlmUniqueID>101778596</NlmUniqueID><ISSNLinking>2173-576X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010348" MajorTopicYN="Y">Patient Care Team</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012512" MajorTopicYN="N">Sarcoma, Ewing</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Childhood tumours</Keyword><Keyword MajorTopicYN="N">Ewing sarcoma</Keyword><Keyword MajorTopicYN="N">Malignant bone tumour</Keyword><Keyword MajorTopicYN="N">Sarcoma Ewing</Keyword><Keyword MajorTopicYN="N">Tumor &#xf3;seo maligno</Keyword><Keyword MajorTopicYN="N">Tumores en infancia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30642764</ArticleId><ArticleId IdType="doi">10.1016/j.recot.2018.10.006</ArticleId><ArticleId IdType="pii">S1888-4415(18)30170-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>